Pharmaceuticals

Chinese Biotech Aims for U.S. Approval of Groundbreaking Cancer Therapy as Merck Faces Competition

23 hours ago

In a bold move signaling the intense competition within the biotechnology sector, a Chinese biotech company is seeking to secure regulatory approval for its innovative cancer therapy in the United States. This development comes as Merck & Co., a leading global player in cancer treatments, faces potential competition that could disrupt its established market dominance.

Temasek's $6.5 Billion Investment Paves the Way for European Expansion Through Swiss Pharma Merger

2 days ago

In a significant move that highlights the growing interest of Asian investors in the European market, Singapore’s sovereign wealth fund, Temasek, has unveiled a groundbreaking merger in the pharmaceutical sector worth $6.5 billion. This strategic alliance marks Temasek's ambitious foray into Europe, aiming to capitalize on the continent's robust healthcare landscape.

Trump Urged to Take Strong Stance Against Big Pharma by Icelandic Drug Manufacturer

5 days ago

A prominent Icelandic drugmaker has issued a call for former President Donald Trump to adopt a more aggressive approach towards the pharmaceutical industry. This appeal follows Trump's criticism of soaring drug prices during his tenure in office and reflects ongoing concerns over affordability and access to essential medications.

Lilly Expands Digital Health Platform to Address Alzheimer’s Disease

5 days ago

In a significant move aimed at combating Alzheimer's disease, Eli Lilly and Company has announced the expansion of its digital health website, which now includes a dedicated section for Alzheimer's disease management and information. This initiative comes as part of Lilly's broader commitment to harness technology to enhance patient care and improve outcomes for those affected by dementia.

Europe Risks Losing Ground to China in the Pharmaceutical Sector, AstraZeneca Chief Warns

6 days ago

In a striking revelation, the CEO of AstraZeneca has issued a warning that Europe is swiftly falling behind China in the race for pharmaceutical innovation and production. The remarks highlight a growing concern within the industry about Europe's competitive edge as Asian markets, particularly China, ramp up their investments and capabilities in biotechnology and pharmaceuticals.

Merck Invests Up to $2 Billion for Rights to Chinese Heart Drug

7 days ago

In a significant move within the pharmaceutical industry, Merck & Co. has announced plans to acquire the rights to a promising heart drug under development in China, with the total investment reaching up to $2 billion. This decision underscores Merck's commitment to expanding its portfolio in the cardiovascular market as part of a broader strategy to enhance its global footprint in the pharmaceutical landscape.

AstraZeneca Strives for Recovery Amidst China Probe with New R&D Hub in Beijing

8 days ago

In a bold move following a recent investigation by Chinese authorities, AstraZeneca is setting up a new research and development hub in Beijing. This initiative marks the pharmaceutical giant's commitment to deepening its presence in China and pivoting past the scrutiny that has affected its operations in the region.

AstraZeneca Unveils Ambitious $2.5 Billion Investment in Beijing Amid Ongoing Probe

11 days ago

In a surprising move that underscores its commitment to expanding operations in Asia, AstraZeneca has announced a substantial investment of $2.5 billion in Beijing, despite facing ongoing scrutiny from regulatory bodies. This significant financial commitment is being interpreted as a bold declaration of confidence in the Chinese market and reflects the pharmaceutical giant's long-term strategic ambitions.

Purdue Pharma Proposes $7 Billion Settlement in Opioid Lawsuit, Involving Sackler Family Contributions

14 days ago

Purdue Pharma, the pharmaceutical company at the center of the opioid crisis in the United States, has put forth a detailed plan to address lawsuits filed against it by various states and municipalities. The proposal includes an unprecedented commitment of up to $7 billion from the Sackler family, the owners of Purdue Pharma. This significant move is aimed at resolving thousands of legal claims tied to the widespread addiction crisis that has devastated countless families and communities across the country.

Pfizer Prepares to Divest Final Share of Haleon as Strategic Shift Takes Shape

14 days ago

Pfizer Inc. is making significant moves as it aims to fully divest its stake in Haleon, the consumer healthcare business it previously shared with GlaxoSmithKline (GSK). The pharmaceutical giant has announced plans to execute a final sale of its shareholding in Haleon, a move that signifies a strategic shift as Pfizer refocuses on enhancing its core pharmaceutical and vaccine operations.